Rockall score in non-variceal upper gastrointestinal bleeding
Upper Gastrointestinal Bleeding
-
Upload
drsathaporn-kunnathum -
Category
Documents
-
view
81 -
download
3
description
Transcript of Upper Gastrointestinal Bleeding
Upper Gastrointestinal Bleeding27 may 2009
Sathaporn Kunnathum M.D.
Overview
• Cause of Gastrointestinal bleeding
• Clinical Presentation
• Evaluation
• Treatment
Introduction
• Causes depend on site– UGI = proximal to ligament of Treitz– LGI = distal to ligament of Treitz
Causes of Significant GI BleedingUpper Percentage Lower Percentage
Peptic ulcer dz
Gastricerosions
Varices
Mallory-Weiss
Esophagitis
Duodenitis
45
23
10
7
6
6
Diverticulosis
Angiodysplasia
Unknown
Cancer/polyps
Rectal disease
IBD
18-43
20-40
11-32
9-33
8-9
1-7
Clinical Presentation
• Most common = hematemesis, melena, hematochezia or black stools– Hematemesis associated with bleeding
proximal to lig of treitz– Melena usually proximal to jejunum with
greater than 4 hrs transit time• requires blood 50-100 mL
Clinical Presentation
– Hematochezia usually due to colonic source BUT UGIB > 1000 mL and less than 4 hours transit may be red or maroon
• UGIB: 71% have melena, 56% hematemesis, 21% maroon stool
Evaluation
• First priority is ABCs• Intubation occasionally necessary for
overwhelming UGIB• Aggressive fluid resuscitate if hemodynamic
unstable = Mandatory to have 2 Large Bore I.V. or central access
• While stabilizing, get initial history, place on monitor and start O2
Evaluation
• History:– Duration, quantity, color of blood, associated
symptoms ,precipitating factor, history of GIB, alcohol, drugs use, underlying disease
Evaluation• Physical Exam Vital signs
– PR, BP, RR– Hypothermia with significant volume depletion
Others
– General appearance: pale?jaundice? conscious?– Skin: turgor, capillary refill, petechiae/purpura– Lungs/Heart– Abdominal exam – PR
Evaluation
• Laboratory – Hct – CBC,plt– PT/PTT for correctable coagulopathy– Cross match – Blood chemistry for azotemia/ARF/Acidosis– LFT– ABG if indicated
Treatment
• NPO
• Always start with ABCs
• O2
• 2 Large bore IVs
• Monitor
• NG tube
• Foley cath
• ET tube ?
Treatment
• NG lavage– Essential to differentiate UGI vs. LGI– 10-15% of pts with hematochezia have UGIB
Treatment
• NG lavage, cont.– 79% sensitive for ACTIVE UGIB– Useful to assess for ongoing hemorrhage – Not therapeutic– Not harmful in varices or MW tear
Treatment
• NG lavage, additional notes– Must confirm placement of tube prior to
lavage– Sterile lavage fluid not necessary– Lavage until clear
Treatment
• Fluid resuscitation– Crystalloid initially– PRC,Fresh whole blood, FFP, plt conc
• Critical to monitor
Treatment
• Coagulation Defects - consider FFP, Vit K
• Thrombocytopenic (<50,000 and bleeding) transfuse platelets
• For severe bleeds - consult GI early as well as general surgery
Treatment
• Additional options– Empiric acid-suppressive therapy : PPI and
H2 receptor antagonist– Octreotide - Besson in NEJM 1995 showed
decreased rebleeding in varices after Octreotide - no change in mortality, however (50 mcg bolus, then 25-50/hr)
Treatment
• Sengstaken-Blakemore Tube– Generally not used except in dire circumstance– High rate of complications and death (14%, 3%)
including aspiration, esophageal and gastric rupture, mucosal and nasal necrosis
– Attempt only after failure of Octreotide as a bridge to endoscopy in pts exsanguinating from known varices
– Need to be intubated prior to placement
Treatment
• Endoscopy– Most accurate tool for evaluating source of
bleeding– Not usually necessary in first 12 hrs
• no increase in diagnostic accuracy if done earlier
– May be necessary if bleeding is ongoing, unresponsive to resuscitation or recurrent to dictate therapy
• Intervention angiography
Treatment
• Surgery– 15-34% of patients with GIB require surgery– Mortality for emergency surgery is 23%
• Thank you for your attention